Dose Finding Trial of Rosuvastatin and Atorvastatin Versus Hepatitis C

Bader, Ted, M.D.

Status and phase: Completed; Phase 2

Conditions: Hepatitis C

Treatments: Drug: rosuvastatin; Drug: atorvastatin

Study type: Interventional

Identifiers

NCT00446940

13133

Details and patient eligibility

About

Different Doses of rosuvastatin and atorvastatin will be used to see if HCV viral load changes and liver tests change.

Enrollment: 16 estimated patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Hepatitis C

Exclusion criteria

• HIV positivity

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)